28.06.2016 Views

Neuropsychiatric Symptoms of Epilepsy

5qIFB7UWr

5qIFB7UWr

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 2<br />

Depression<br />

Andres M. Kanner and Ramses Ribot<br />

Abstract Depressive disorders are the most frequent psychiatric comorbidity in<br />

people with epilepsy, with lifetime prevalence rates <strong>of</strong> 30–35 %. Their prevalence is<br />

also higher than in the general population, and in particular, in people with poorly<br />

controlled seizures. In addition, there is a complex relation between epilepsy and<br />

depressive disorders, whereby not only are patients with epilepsy at greater risk <strong>of</strong><br />

developing depressive disorders, but patients with primary depressive disorders are<br />

at greater risk <strong>of</strong> developing epilepsy. In this chapter, we review the salient aspects<br />

<strong>of</strong> depressive disorders in epilepsy that any clinician treating people with epilepsy<br />

must know.<br />

Keywords Major Depressive Disorder • Postictal Depression • Ictal Depression •<br />

Suicidality • Antidepressant Drugs<br />

Introduction<br />

Depressive disorders are the most frequent psychiatric comorbidity in people with<br />

epilepsy (PWE), with lifetime prevalence rates ranging from 30 to 35 % [ 1 ]. Higher<br />

prevalence rates (21–33 %) have been also found in patients with persistent seizures<br />

when compared to seizure-free patients (4–6 %) in several cross-sectional studies<br />

[ 2 – 4 ]. Furthermore, a population-based survey <strong>of</strong> 185,000 households, which<br />

screened for lifetime symptoms <strong>of</strong> depression yielded higher rates in PWE than<br />

those with other chronic conditions [ 5 ], with at least one episode <strong>of</strong> symptoms <strong>of</strong><br />

depression reported by 32 % <strong>of</strong> PWE, compared to 16 % <strong>of</strong> patients with asthma, 13<br />

% with diabetes, and 8.6 % <strong>of</strong> healthy respondents. Similar prevalence rates have<br />

been identified in children and adolescents with epilepsy [ 6 ].<br />

A. M. Kanner , MD, FANA (*) • R. Ribot , MD<br />

<strong>Epilepsy</strong> Section, Department <strong>of</strong> Neurology , Comprehensive <strong>Epilepsy</strong> Center,<br />

University <strong>of</strong> Miami, Miller School <strong>of</strong> Medicine ,<br />

1120 NW 14th Street, Room 1324 , Miami , FL , 33136 , USA<br />

EEG Monitoring Unit , University <strong>of</strong> Miami Hospital,<br />

University <strong>of</strong> Miami, Miller School <strong>of</strong> Medicine ,<br />

1120 NW 14th Street, Room 1324 , Miami , FL , 33136 , USA<br />

e-mail: a.kanner@med.miami.edu<br />

© Springer International Publishing Switzerland 2016<br />

M. Mula (ed.), <strong>Neuropsychiatric</strong> <strong>Symptoms</strong> <strong>of</strong> <strong>Epilepsy</strong>, <strong>Neuropsychiatric</strong><br />

<strong>Symptoms</strong> <strong>of</strong> Neurological Disease, DOI 10.1007/978-3-319-22159-5_2<br />

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!